AMG386 Comb w. Either Pegylated Liposomal Doxorubicin or Topotecan Subjects w. Advanced Recurrent Epithelial Ovarian CR

Clinical trial NCT00770536 · COMPLETED

Trial details

NCT number: NCT00770536
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Cancer Carcinoma Fallopian Tube Cancer Gynecological Malignancies Metastases Oncology Ovarian Cancer Solid Tumors Tumors

Start date: 2009-01-01
Primary completion: 2012-01-01
Enrollment: 103

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.